ABT vs TMDX
Abbott Laboratories · TransMedics Group Inc
Relative return (rebased to 100)
Key stats
| Metric | ABT | TMDX |
|---|---|---|
| Price | $112.47 | $88.43 |
| Market Cap | $195.90B | $3.06B |
| P/E | 30.03 | 16.06 |
| P/B | 3.76 | 6.19 |
| P/S | 4.42 | 5.05 |
| ROE | 12.5% | 38.5% |
| Net Margin | 14.7% | 31.4% |
| Gross Margin | — | 59.9% |
| Revenue Growth | 5.7% | 37.1% |
| Dividend Yield | 2.13% | — |
| EPS | $3.75 | $5.51 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.